Itron (NASDAQ:ITRI) Posts Earnings Results, Beats Expectations By $0.30 EPS

Itron (NASDAQ:ITRI) released its quarterly earnings data on Tuesday. The scientific and technical instruments company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.29 by $0.30, Briefing.com reports. Itron had a return on equity of 19.54% and a net margin of 12.31%.During the same period in the prior year, the firm earned $1.62 earnings per share. The firm’s quarterly revenue was down 7.2% on a year-over-year basis. Itron updated its Q3 2026 guidance to 1.500-1.600 EPS and its FY 2026 guidance to 6.300-6.500 EPS.

Itron Price Performance

Shares of ITRI opened at $84.78 on Tuesday. The company’s 50-day moving average is $83.04 and its 200-day moving average is $89.73. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. The firm has a market capitalization of $3.76 billion, a PE ratio of 13.52, a PEG ratio of 0.74 and a beta of 1.32. Itron has a fifty-two week low of $77.77 and a fifty-two week high of $142.00.

Insider Buying and Selling

In related news, SVP John F. Marcolini sold 322 shares of the company’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $27,167.14. Following the transaction, the senior vice president owned 24,689 shares in the company, valued at approximately $2,083,010.93. This represents a 1.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $26,914.03. Following the completion of the transaction, the senior vice president directly owned 29,100 shares in the company, valued at approximately $2,455,167. This represents a 1.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 3,946 shares of company stock valued at $324,420. Company insiders own 1.77% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Soros Fund Management LLC bought a new position in Itron during the 4th quarter worth $34,843,000. Millennium Management LLC increased its holdings in shares of Itron by 269.3% during the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock worth $47,068,000 after purchasing an additional 369,617 shares during the period. Merewether Investment Management LP raised its position in shares of Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after buying an additional 282,587 shares in the last quarter. Schroder Investment Management Group boosted its stake in shares of Itron by 65.2% in the fourth quarter. Schroder Investment Management Group now owns 588,872 shares of the scientific and technical instruments company’s stock valued at $54,683,000 after buying an additional 232,341 shares during the period. Finally, Jacobs Levy Equity Management Inc. acquired a new stake in Itron during the fourth quarter worth approximately $19,133,000. 96.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ITRI. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a research report on Friday, May 8th. Zacks Research lowered shares of Itron from a “hold” rating to a “strong sell” rating in a research note on Friday, July 17th. Raymond James Financial started coverage on shares of Itron in a report on Tuesday, April 21st. They set an “underperform” rating for the company. JPMorgan Chase & Co. lowered their target price on shares of Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Finally, Roth Capital reiterated a “buy” rating and issued a $136.00 target price on shares of Itron in a report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $131.22.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.